Skip to content

Red Cell Distribution Width and Lactate Albumin Ratio as Prognostic Markers for Mortality in Sepsis and Septic Shock

Red Cell Distribution Width and Lactate Albumin Ratio as Prognostic Markers for Mortality in Sepsis and Septic Shock Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05921825
Enrollment
70
Registered
2023-06-27
Start date
2023-07-01
Completion date
2024-01-30
Last updated
2023-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morality, Sepsis, Septic Shock

Brief summary

The aim of this study is to find the utility of red cell distribution width and lactate/albumin ratio as prognostic markers in sepsis and septic shock patients.

Detailed description

Several indicators are being used to predict the prognosis of sepsis. Commonly used prognostic indicators include Acute Physiological and chronic health evaluation II (APACHE II), Sequential Organ Failure Assessment (SOFA), Mortality in Emergency Department Score (MEDS), New York Sepsis severity score. Red cell distribution Width and lactate albumin ratio are being investigated for there prognostic value in septic patients.

Interventions

Blood will be drawn from the peripheral vein, arterial or a central catheter. This procedure will be done at diagnosis, 3 ,7, 14 and 21 days of sepsis

DIAGNOSTIC_TESTlactate albumin ratio measurement

Blood will be drawn from the peripheral vein, arterial or a central catheter. This procedure will be done at diagnosis, 3 ,7, 14 and 21 days of sepsis

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1. Age from 18 to 60 years old. 2. Clinical criteria of sepsis 3. Or clinical criteria of septic shock including sepsis with persisting hypotension requiring vasopressors to maintain mean arterial pressure \> 65 mmHg and having a serum lactate level \> 2 mmol/L despite adequate volume resuscitation.

Exclusion criteria

1. No informed consent. 2. Patient with incomplete information and data. 3. The patient who received blood transfusion within 90 days before emergency admission. 4. The patients who are known to have long-term conditions causing anemia like sickle cell anemia, thalassemia, iron deficiency anemia. 5. Malignancy and chemotherapy during the previous 90 days. 6. Patients with either hepatic dysfunction, renal failure, having any disease in which albumin should be supplemented as liver cirrhosis with ascites, nephrotic syndrome and burns.

Design outcomes

Primary

MeasureTime frameDescription
The prediction of mortality28 daysThe diagnostic accuracy for prediction of 28th day mortality by Red cell distribution Width and lactate albumin ratio.

Secondary

MeasureTime frameDescription
Length of intensive care stay28 days or till discharge from intensive care.Length of intensive care stay from admission till discharge either to the ward or mortality.
Extent of organ dysfunctions in patients with severe sepsis and septic shock28 daysOrgan dysfunction can be confirmed by acute change in sepsis-related organ failure assessment (SOFA).

Countries

Egypt

Contacts

Primary ContactShimaa S Awd, MBBCh
shimaa_saad@med.tanta.edu.eg+20 101 011 6084

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026